Regeneron Pharmaceuticals, Inc. · NASDAQ:REGN
Ryan Arthur F sold 100 Regeneron Pharmaceuticals, Inc. shares (Form 4)
Traded Apr 1, 2026 · Filed Apr 3, 2026
On Apr 1, 2026, Ryan Arthur F (Director) sold 100 Regeneron Pharmaceuticals, Inc. shares at an average US$777.27 for US$77,727 under a trading plan, leaving 17,603 shares. Filed Apr 3, 2026 (Form 4).
- Sold
- 100 shares
- Price
- US$777.27 average (US$771.32 to US$779.71)
- Value
- US$77,727
- Holding after
- 17,603 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | Sale | 1 | US$771.32 | 17,702 | Direct |
| Apr 1, 2026 | Common Stock | Sale | 3 | US$772.76 | 17,699 | Direct |
| Apr 1, 2026 | Common Stock | Sale | 8 | US$773.59 | 17,691 | Direct |
| Apr 1, 2026 | Common Stock | Sale | 8 | US$774.58 | 17,683 | Direct |
| Apr 1, 2026 | Common Stock | Sale | 14 | US$775.58 | 17,669 | Direct |
| Apr 1, 2026 | Common Stock | Sale | 13 | US$776.62 | 17,656 | Direct |
| Apr 1, 2026 | Common Stock | Sale | 9 | US$777.42 | 17,647 | Direct |
| Apr 1, 2026 | Common Stock | Sale | 4 | US$778.24 | 17,643 | Direct |
| Apr 1, 2026 | Common Stock | Sale | 40 | US$779.71 | 17,603 | Direct |
Source
Related
- Regeneron Pharmaceuticals, Inc.
- Ryan Arthur F
- Regeneron Pharmaceuticals, Inc. shareholders
- Form 4 · Ryan Arthur F · Jul 7, 2026
- Form 4 · Ryan Arthur F · May 4, 2026
- Form 4 · Murphy Andrew J · Oct 15, 2026
- Form 4 · McCourt Marion · Sep 3, 2026
- Form 4 · Guarini Kathryn · Sep 3, 2026
- Form 4 · Larosa Joseph J · Aug 21, 2026
- Form 4 · Fenimore Christopher R. · Aug 20, 2026